
Innovation-led coronavirus NGS solutions and integrated bioinformatics
Emerging pandemics require accelerated development of innovative technologies to enable faster mitigatory responses. Advances in molecular epidemiology by examining pathogen phylogenetics and virus strain evolution, as well as insights into pathogen-host-microbiome interactions and metatranscriptomics can trigger developments in phylogeographic tracking, as well as vaccine and drug discovery research. With innovation at the heart of its mission, partner with QIAGEN to benefit from the full spectrum of our high-performance NGS solutions and integrated bioinformatics pipelines that collectively drive a greater understanding of the multiple facets of SARS-CoV-2 biology.
Coronavirus research publications using QIAGEN technologies
- Itokawa, K., Sekizuka, T., Hashino, M., Tanaka, R., and Kuroda, M. (2020)
A proposal of an alternative primer for the ARTIC Network’s multiplex PCR to improve coverage of SARS-CoV-2 genome sequencing. - Itokawa, K., Sekizuka, T., Hashino, M., Tanaka, R., and Kuroda, M. (2020)
Disentangling primer interactions improves SARS-CoV-2 genome sequencing by the ARTIC Network’s multiplex PCR. - Maitra, A. et al. (2020)
Mutations in SARS-CoV-2 viral RNA identified in Eastern India: Possible implications for the ongoing outbreak in India and impact on viral structure and host susceptibility. - Hartley et al. (2020)
Genomic evidence for a case of reinfection with SARS-CoV-2 - Tillett et al. (2020)
Genomic surveillance revealed prevalence of unique SARS-CoV-2 variants bearing mutation in the RdRp gene among Nevada patients
Coronavirus webinars
Sign up for our informative live webinars exploring different themes in coronavirus research.
-
Using targeted whole viral genome sequencing to understand COVID-19Speaker: Brian Dugan, M.S., Associate Director, Global Product Management, Genomics, QIAGEN
On-demand recorded webinar -
rRNA removal for RNA-seq applications involving viruses, host responses and metatranscriptomicsSpeaker: Samuel Rulli, Ph.D., Associate Director, RNA-seq profiling, NGS assay technologies, QIAGEN
On-demand recorded webinar -
Targeted RNA panels to identify SARS-CoV-2 and study host gene expressionSpeaker: Samuel Rulli, Ph.D., Associate Director, RNA-seq profiling, NGS assay technologies, QIAGEN
On-demand recorded webinar